SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 81 filers reported holding SYNERON MEDICAL LTD in Q2 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,176,000 | +575.9% | 111,476 | +438.8% | 0.06% | +463.6% |
| Q4 2016 | $174,000 | +59.6% | 20,691 | +36.2% | 0.01% | +83.3% |
| Q3 2016 | $109,000 | +19.8% | 15,191 | +28.8% | 0.01% | -14.3% |
| Q2 2016 | $91,000 | -28.3% | 11,791 | -32.2% | 0.01% | -12.5% |
| Q1 2016 | $127,000 | -5.2% | 17,391 | 0.0% | 0.01% | -55.6% |
| Q4 2015 | $134,000 | +8.1% | 17,391 | +0.2% | 0.02% | +500.0% |
| Q3 2015 | $124,000 | -34.4% | 17,348 | -2.8% | 0.00% | -40.0% |
| Q2 2015 | $189,000 | -44.9% | 17,842 | -35.7% | 0.01% | -44.4% |
| Q1 2015 | $343,000 | +75.9% | 27,737 | +77.2% | 0.01% | +80.0% |
| Q1 2014 | $195,000 | – | 15,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $31,650,000 | 4.86% |
| Discovery Group I, LLC | 1,221,310 | $12,885,000 | 4.30% |
| Kenmare Capital Partners, L.L.C. | 389,177 | $4,106,000 | 3.98% |
| Profit Investment Management, LLC | 237,217 | $2,503,000 | 2.03% |
| Senvest Management, LLC | 2,202,272 | $23,234,000 | 1.66% |
| PERRITT CAPITAL MANAGEMENT INC | 426,370 | $4,498,000 | 1.14% |
| Camber Capital Management LP | 2,347,593 | $24,767,000 | 1.00% |
| DALTON GREINER HARTMAN MAHER & CO | 1,645,048 | $17,355,000 | 0.99% |
| Lapides Asset Management, LLC | 396,800 | $4,186,000 | 0.78% |
| DAFNA Capital Management LLC | 85,947 | $907,000 | 0.77% |